Location of Repository

Prevention and treatment of venous thromboembolism with low-molecular-weight heparins: Clinical implications of the recent European guidelines

By Prandoni Paolo

Abstract

<p>Abstract</p> <p>Venous thromboembolism (VTE) is an important cause of avoidable morbidity and mortality. However, routine prophylaxis for at-risk patients is underused. Recent guidelines issued by an international consensus group, including the International Union of Angiology (IUA), recommend use of low-molecular-weight heparins (LMWHs) for the treatment of acute VTE and prevention of recurrence, and for prophylaxis in surgical and medical patients. This review highlights current inadequacies in the provision of thromboprophylaxis, and considers the clinical implications of the European guidelines on the prevention and treatment of VTE.</p

Topics: Diseases of the circulatory (Cardiovascular) system, RC666-701, Specialties of internal medicine, RC581-951, Internal medicine, RC31-1245, Medicine, R, DOAJ:Cardiovascular, DOAJ:Medicine (General), DOAJ:Health Sciences, Diseases of the blood and blood-forming organs, RC633-647.5
Publisher: BioMed Central
Year: 2008
DOI identifier: 10.1186/1477-9560-6-13
OAI identifier: oai:doaj.org/article:3ec6a01bc4e045f9a35071b8da964d41
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://doaj.org/toc/1477-9560 (external link)
  • http://www.thrombosisjournal.c... (external link)
  • https://doaj.org/article/3ec6a... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.